DXB
Dimerix
Pharmaceuticals, Biotechnology & Life Sciences
is a clinical stage biopharmaceutical company with a scalable, proprietary platform technology called Receptor-HIT. Incorporated in 2004, Dimerix develops and commercialises patient preferred pharmaceutical products for global markets using our innovative
Shorted
short percentage0.15%
reported shorts877.9K
shares on issue600.397M
About
website
industry
address
Key Metrics
market cap
$303.20Meps$-0.02
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Short Position Trends
Track bearish sentiment and short interest over time
Historical Price Data
View stock price movements, volume, and trading patterns